Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The "Europe Precision Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, and End User" study has been added to ResearchAndMarkets.com's offering.
The precision diagnostics marketplace successful Europe is expected to turn from US$ 23,317.64 cardinal successful 2022 to US$ 48,500.85 cardinal by 2028. It is estimated to turn astatine a CAGR of 13.0% from 2022 to 2028.
Healthcare is entering the epoch of personalized approaches, with attraction tailored to precise illness patterns. Advanced-stage illness diagnosis has little endurance rates, higher attraction morbidity, and higher healthcare costs. As the archetypal measurement successful personalized medicine, diagnosis aims to qualify diseases based connected patient-specific accusation and observe and forestall diseases arsenic aboriginal arsenic possible. For example, the 5-year endurance complaint for non-small compartment lung crab (NSCLC) is expected to summation to implicit 90% for patients diagnosed astatine the earliest stage, compared to lone 10% astatine the metastatic stage.
Precision diagnostics assists successful providing a precise and timely mentation of a patient's wellness problem, allowing attraction to beryllium delivered promptly. There is simply a greater request for personalized medicine owed to advancements successful genomics probe and biomarkers owed to the ratio and target-specific quality of personalized medicine with amended diligent outcomes. The increasing request for personalized medicine and attraction procedures is surging the request for diagnostic products, arsenic it allows aesculapian professionals to diagnose patients and lick wellness problems accurately.
Personalized therapy is disposable to patients with an knowing of the molecular ground of diseases. It is gaining popularity, wherever familial investigating and genome sequencing are indispensable tools to recognize illness molecular basis. Advances successful caller diagnostic tools that let for adjacent greater precision are advancing further. In addition, galore familial disorders are screened for successful European countries, arsenic aboriginal detection of these diseases prevents the onset of symptoms oregon reduces illness severity. For example, the abrupt summation successful COVID-19 pandemic cases accelerated the request for effectual diagnostic procedures and products.
Diagnostic investigating was the backbone of the COVID-19 response, supporting containment efforts to trim the cases, and accelerating the uptake of diagnosing solutions to supply patients with aboriginal treatment. Therefore, the expanding request for the aboriginal diagnosis of diseases done precision diagnostic tests is driving the market.
Europe Precision Diagnostics Market Segmentation
The Europe precision diagnostics marketplace is segmented by type, application, extremity user, and country.
- Based connected type, the marketplace is segmented into familial tests, esoteric tests, and others. The familial tests conception dominated the marketplace successful 2022.
- Based connected application, the marketplace is fragmented into oncology, cardiology, immunology, respiratory diseases, and others. The oncology conception dominated the marketplace successful 2022.
- Based connected extremity user, the marketplace is segmented into hospitals, objective laboratories, location care, and others. The objective laboratories conception dominated the marketplace successful 2022.
- Based connected country, the marketplace is segmented into Germany, France, the UK, Italy, Spain, and the remainder of Europe. Further, Germany dominated the marketplace successful 2022.
Market Dynamics
Key Market Drivers
- Growing Demand for Personalized Medicine
- Rising Application successful Oncology and Other Disorders
Market Restraints
- High Investments Involved successful the R&D of Precision Medicine and Diagnostic Kits
Market Opportunities
- Growing Advancement In Digital Solutions
Future Trends
- Usage of Artificial Intelligence and Machine Learning successful Precision Diagnostics
| Report Attribute | Details |
| No. of Pages | 149 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value (USD) successful 2022 | $23317.64 Million |
| Forecasted Market Value (USD) by 2028 | $48500.85 Million |
| Compound Annual Growth Rate | 13.0% |
| Regions Covered | Europe |
Key Topics Covered:
1. Introduction
2. Europe Precision Diagnostics Market - Key Takeaways
3. Research Methodology
4. Europe Precision Diagnostics Market - Market Landscape
5. Europe Precision Diagnostics Market - Key Market Dynamics
6. Precision Diagnostics Market- Europe Analysis
7. Europe Precision Diagnostics Market- by Type
8. Europe Precision Diagnostics Market- by Application
9. Europe Precision Diagnostics Market- by End User
10. Europe Precision Diagnostics Market- by Country
11. Europe Precision Diagnostics Market -Industry Landscape
12. Company Profiles
13. Appendix
Companies Mentioned
- Abbott
- Bayer AG
- Koninklijke Philips N.V.
- Lantheus Medical Imaging, Inc.
- Novartis AG
- QIAGEN
- Quest Diagnostics Incorporated
- Sanofi
- Siemens Healthineers AG
- Swiss Precision Diagnostics GmbH
For much accusation astir this study sojourn https://www.researchandmarkets.com/r/ud5jw5
English (US)